Author Affiliations: The Centre for Hip Health and Mobility (Drs Davis and Liu-Ambrose) and The Brain Research Centre (Drs Beattie, Graf, and Liu-Ambrose and Ms Nagamatsu), Vancouver Coastal Health Research Institute, Collaboration for Outcomes Research and Evaluation (CORE), Faculty of Pharmaceutical Sciences (Drs Davis and Marra and Mr Najafzadeh), Department of Physical Therapy (Dr Liu-Ambrose), Department of Psychology (Dr Graf), and Division of Geriatric Medicine, Faculty of Medicine (Dr Beattie), University of British Columbia, Vancouver, British Columbia, Canada; and Otago School of Medicine, University of Otago, Dunedin, New Zealand (Dr Robertson).
Cognitive decline is a major public health care issue, and a well-recognized clinical manifestation of cognitive decline is falls. Seniors with cognitive impairment fall at twice the rate of peers without cognitive impairment.1,2
Exercise training may be an effective strategy against cognitive decline,3- 6 and it is recommended for prevention of falls. We recently reported that 12 months of once-weekly (1 × RT) or twice-weekly (2 × RT) resistance training improved selective attention and conflict resolution compared with a balance and tone program (BAT; control) among 155 community-dwelling senior women (ie, Brain Power resistance training study).4We also found that both resistance training programs provided better value for falls prevented compared with the BAT program.7To our knowledge, no study has examined whether both cognitive and economic benefits of exercise persist after formal cessation. Hence, we examined whether improved selective attention and conflict resolution as well as economic benefits were sustained 12 months after formal cessation of the Brain Power resistance training study.
We conducted a 12-month follow-up study from May 2008 to April 2009. Of the original 155 participants, 123 consented to the follow-up study. Ethics approval was obtained from the Vancouver Coastal Health Research Institute and the University of British Columbia's Clinical Research Ethics Board.
Our primary outcome measure was the specific executive cognitive function of selective attention and conflict resolution, as measured by the Stroop Test.8 Secondary measures included set shifting, working memory, and current physical activity level.
Between-group differences in executive cognitive functions were compared by multiple linear regression analyses as in our original trial.4 For current physical activity level, baseline score and experimental group were used as covariates. Two planned simple contrasts were performed to assess differences between (1) the 1 × RT group and the BAT group and (2) the 2 × RT group and the BAT group. The overall α level was set at P < .05.
For the economic evaluation, we calculated the incremental cost per fall prevented for both 1 × RT and 2 × RT groups compared with the BAT group from a Canadian Health Care System perspective using a 21-month time horizon (2009 prices). All hospital admission–related costs were based on a fully allocated cost model of a tertiary care hospital or the British Columbia Medical Services Plan 2009 price list.
Of the 123 who consented, 109 completed the assessment at the end of the 12-month follow-up (37 from the 1 × RT group, 41 from the 2 × RT group, and 31 from the BAT group). The mean (SD) age of the cohort was 71.6 (3.0) years.
There was a significant between-group difference in selective attention and conflict resolution at the end of the 12-month follow-up study (P = .04). Specifically, the 1 × RT group sustained improved Stroop test performance compared with the BAT group (P = .04) (Table). There were no significant between-group differences in set shifting, working memory, and current physical activity level.
The unadjusted incidence rate ratio over the 2-year period for the 1 × RT group indicated a 30% (incidence rate ratio, 0.70; 95% confidence interval, 0.37-1.33) nonsignificant reduction in falls and an 8% (incidence rate ratio, 1.08; 95% confidence interval, 0.79-1.47) nonsignificant increase in the 2 × RT group.
On the basis of the point estimates from our base case analysis, we found that the 1 × RT group incurred fewer health care resource utilization costs and had fewer falls than the BAT group; thus, 1 × RT was less costly and more effective than BAT. Although the 2 × RT group also incurred fewer care utilization costs than BAT, the 2 × RT group sustained more falls. Thus, 2 × RT was less effective than BAT.
We provide novel data suggesting that both the cognitive and economic benefits of once-weekly resistance training can be sustained 12 months after its formal cessation. Specifically, 12 months after trial completion, former participants of the 1 × RT group demonstrated a 15% improvement in their performance on the Stroop test compared with those in the BAT group. This novel finding strengthens the emerging belief that targeted exercise training may combat age-related decreases in cognitive function. Furthermore, there was a significant reduction in health care resource utilization costs of falls 12 months after trial completion for the 1 × RT and 2 × RT groups compared with the BAT (control) group. Thus, both cognitive and economic benefits of participating in a 12-month resistance training intervention were sustained for the 1 × RT group, whereas these benefits were not sustained for the 2 × RT group. The 1 × RT group demonstrated a 5% increase (P > .05) in current physical activity level from baseline compared with a 6.6% reduction (P > .05) in the 2 × RT group. Hence, maintaining physical activity level may be essential in sustaining the benefits of resistance training. Such findings should remain guarded as future studies investigate factors that explain this observed variation in exercise-induced cognitive benefits in terms of costs and consequences.
Correspondence: Dr Liu-Ambrose, Department of Physiotherapy, University of British Columbia, 311-2647 Willow St, Vancouver, BC V5Z 3P1, Canada (firstname.lastname@example.org).
Author Contributions: All authors had full access to all of the data (including statistical reports and tables) in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Study concept and design: Marra, Beattie, Graf, and Liu-Ambrose. Acquisition of data: Nagamatsu and Liu-Ambrose. Analysis and interpretation of data: Marra, Beattie, Robertson, Najafzadeh, Nagamatsu, and Liu-Ambrose. Drafting of the manuscript: Liu-Ambrose. Critical revision of the manuscript for important intellectual content: Marra, Beattie, Robertson, Najafzadeh, Graf, Nagamatsu, and Liu-Ambrose. Statistical analysis: Marra, Najafzadeh, and Liu-Ambrose. Obtained funding: Beattie, Graf, and Liu-Ambrose. Administrative, technical, and material support: Nagamatsu and Liu-Ambrose. Study supervision: Marra, Robertson, and Liu-Ambrose.
Financial Disclosure: None reported.
Funding/Support: The Vancouver Foundation (BCMSF, operating grant to Dr Liu-Ambrose) and the MSFHR (establishment grant to Dr Liu-Ambrose) provided funding for this study. The Canada Foundation for Innovation funded essential infrastructure used in this study (new opportunities fund to Dr Liu-Ambrose).
Trial Registration: clinicaltrials.gov Identifier: NCT00426881
Additional Information: Drs Marra and Liu-Ambrose are Michael Smith Foundation for Health Research Scholars. Dr Marra is a Canada Research Chair in Pharmaceutical Outcomes. Dr Davis is a Canadian Institutes for Health Research Canada Graduate Scholarship PhD trainee.
Additional Contributions: We thank the Vancouver South Slope YMCA management and members who enthusiastically supported the study by allowing access to participants for the training intervention and the instructors for their commitment to the participants' health and safety.
Thank you for submitting a comment on this article. It will be reviewed by JAMA Internal Medicine editors. You will be notified when your comment has been published. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest*
Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Purchase Online Access to this article for 24 hours
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 8
Customize your page view by dragging & repositioning the boxes below.
and access these and other features:
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.